During the past decade, Emergency University Hospital, Bucharest conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emergency University Hospital, Bucharest" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Shire" with 3 trials sponsored, "Carol Davila University of Medicine and Pharmacy" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emergency University Hospital, Bucharest" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brno Epilepsy Center" with 1 trials as a collaborator, "Carlo Besta Institure, Milano" with 1 trials as a collaborator, "Centro Hospitalar e Universitário de Coimbra, E.P.E." with 1 trials as a collaborator and "Christian Doppler Klinik, Salzburg" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Emergency University Hospital, Bucharest" are "Crohn's Disease" (3 trials), "Polycythemia Vera" (2 trials), "Atrial Fibrillation" (1 trials), "Brain Imaging" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Emergency University Hospital, Bucharest" in a lesser frequency.

Most popular intervention types in "Emergency University Hospital, Bucharest" are "Drug" (15 trials), "Other" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (2 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emergency University Hospital, Bucharest" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Emergency University Hospital, Bucharest". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Emergency University Hospital, Bucharest, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Emergency University Hospital, Bucharest, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".